These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1219 related items for PubMed ID: 16181219

  • 1. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ.
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [Abstract] [Full Text] [Related]

  • 2. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group.
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [Abstract] [Full Text] [Related]

  • 3. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 4. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC.
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [Abstract] [Full Text] [Related]

  • 5. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group.
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [Abstract] [Full Text] [Related]

  • 6. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR, Kiely P, Keller AJ.
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [Abstract] [Full Text] [Related]

  • 7. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ.
    N Engl J Med; 1996 Jun 27; 334(26):1685-90. PubMed ID: 8637512
    [Abstract] [Full Text] [Related]

  • 8. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L, AbdulRahman M, John TJ, AlHashimi A.
    Transfusion; 2012 Nov 27; 52(11):2300-9. PubMed ID: 22691239
    [Abstract] [Full Text] [Related]

  • 9. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
    Shang G, Seed CR, Wang F, Nie D, Farrugia A.
    Transfusion; 2007 Mar 27; 47(3):529-39. PubMed ID: 17319836
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A.
    Transfusion; 2009 Oct 27; 49(10):2214-20. PubMed ID: 19527477
    [Abstract] [Full Text] [Related]

  • 11. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B, Schreiber GB, Glynn SA, Kleinman S, Wright DJ, Murphy EL, Busch MP, Retrovirus Epidemiology Donor Study.
    Transfusion; 2005 Jul 27; 45(7):1089-96. PubMed ID: 15987352
    [Abstract] [Full Text] [Related]

  • 12. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G.
    CMAJ; 2003 Oct 14; 169(8):767-73. PubMed ID: 14557314
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.
    Transfusion; 2008 Jun 14; 48(6):1198-206. PubMed ID: 18422856
    [Abstract] [Full Text] [Related]

  • 17. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S, Maniez M, Barlet V, El Ghouzzi MH, Le Vacon F, Levayer T, Lunel F, Morel P, Mouillot L, Piquet Y, Pillonel J, Transfusion-Transmissible Agents Working Group, French National Society of Blood Transfusion.
    Transfusion; 2008 Nov 14; 48(11):2308-14. PubMed ID: 18673347
    [Abstract] [Full Text] [Related]

  • 18. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
    Offergeld R, Faensen D, Ritter S, Hamouda O.
    Euro Surveill; 2005 Feb 14; 10(2):8-11. PubMed ID: 15735310
    [Abstract] [Full Text] [Related]

  • 19. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
    Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH, NHLBI-REDS NAT Study Group.
    Transfusion; 2005 Feb 14; 45(2):254-64. PubMed ID: 15660836
    [Abstract] [Full Text] [Related]

  • 20. Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center.
    Ouattara H, Siransy-Bogui L, Fretz C, Diane KM, Konate S, Koidio A, Minga KA, Hyda J, Koffi-Abe N, Offoumou AM, Abissey S.
    Transfus Clin Biol; 2006 Oct 14; 13(4):242-5. PubMed ID: 16822686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.